NCT00711737

Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months

Open-label Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 27 (actual)
• Sponsor: Changi General Hospital · Academic / Other
• Sex: All
• Age: 21 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to explore the changes in metabolic parameters in patients treated with escitalopram for six months for major depression, generalized anxiety disorder or panic disorder, with or without agoraphobia.

Detailed description

This is an open-label study, with 4 scheduled visits. Recruitment of 100 subjects. Assessments include demographics, diagnosis, smoking frequency, Clinical Global Scale (CGI-S), weight, height,blood pressure, waist and hip circumference and fasting blood glucose and lipd profile. Statistical analysis will be exploratory and mainly descriptive.

Conditions

• Major Depression
• Generalized Anxiety Disorder
• Panic Disorder

Timeline

• Start date: 2008-09-01
• Primary completion: 2010-10-01
• Completion: 2010-10-01
• First posted: 2008-07-09
• Last updated: 2011-06-17

Locations

1 site across 1 country: Singapore